Discover open access scientific publications

Search, annotate, share and cite publications

Publications by T Annable

Combination Therapy for Treating Breast Cancer Using Antiestrogen, ERA-923, and the Mammalian Target of Rapamycin Inhibitor, Temsirolimus

Endocrine-Related Cancer

Cancer Research

English

Related publications

Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin

Clinical Cancer Research

Cancer Research

English

New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists

Breast Cancer Research

Cancer Research

English

Targeting the Mammalian Target of Rapamycin (mTOR): A New Approach to Treating Cancer

British Journal of Cancer

Cancer Research

English

The Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Early Breast Cancer: Results of a Pre-Operative Study

Breast Cancer Research and Treatment

Cancer Research

English

Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells

Cancer Research

Cancer Research

English

Correction: An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1.

Journal of Biological Chemistry

Molecular Biology

English

Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

Current Neurology and Neuroscience Reports

English

Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)

Biochemical Journal

Molecular Biology

English

Immunohistochemical Analysis of Phosphorylated Mammalian Target of Rapamycin and Its Downstream Signaling Components in Invasive Breast Cancer

Molecular Medicine Reports

Molecular Biology

Cancer Research

Molecular Medicine

English